Petr Sedivy1, Barbora Setinova1, Martin Burian1, Dita Pajuelo1, Milan Hajek1, Viktor Sebo2, Michal Koc2, Michaela Siklova2, Marina Henikova2, Eva Krauzova3, Jan Gojda2, Lenka Rossmeislova2, Jan Kovar4, and Monika Dezortova1
1MR-Unit, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, 2Department of Pathophysiology, Third Faculty of Medicine, Charles University, University Hospital Královské Vinohrady, Prague, Czech Republic, 3Department of Internal Medicine, Third Faculty of Medicine, Charles University, University Hospital Královské Vinohrady, Prague, Czech Republic, 4Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
Synopsis
Keywords: Liver, Metabolism, fat fraction, liver steatosis, intra- and extramyocellular fat, calf muscle
The effect of a 28-day
isocaloric ketogenic diet followed by a 2-day carbohydrate realimentation on
adipose tissue and fat content in the liver and calf muscle in 22 obese women was
studied using MRS and MRI methods. During the ketogenic diet, there was a
significant decrease in liver fat volume (69±20 ml, i.e. decrease 43±4% of
basal value) and liver fat content (2.7±0.6 %, i.e. 35±5% of basal value) and
reduction cross-section in both subcutaneous (6 %) and visceral (7 %) fat. Contrary,
the intramyocellular fat increased during the diet.
INTRODUCTION
The ketogenic diet (KD)
has been extensively studied in the context of metabolic health. KD effectively
reduces not only adipose tissue [1] but also hepatic steatosis [2]. However,
most studies with KD have been conducted with reduced caloric intake, therefore
it is not clear yet whether reduction of volume of adipose tissue and lipid
content in the liver and muscle is due to ketosis induction or to low caloric
intake.METHODS
Twenty-two obese women (age = 36.5±1.2 years, BMI = 36.4±0.74
kg/m2) underwent 28 days of isocaloric KD (<50 g carbohydrates/day,
i.e. 6-12% of daily intake). The KD diet was provided by a delivery food
service and caloric intake was calculated individually for each woman. The KD
was followed by 48h of isocaloric high carbohydrate refeeding (60-65% of daily
intake).
All women underwent three MR sessions on 3T MR system VIDA (Siemens Healthineers,
Germany) - before diet (baseline), on the last day of KD, and on the day of the
end of realimentation. The MR examination consisted of MRI and MRS of the liver and calf
muscle and MR volumetry of adipose tissue. The study was conducted in
compliance with the principles of the Declaration of Helsinki and with the
approval of local ethics committee.
Hepatic fat
evaluation
Hepatic
fat fraction (FF) was measured by LiverLab engine consisted of T1 VIBE e-Dixon and
single voxel spectroscopic technique HISTO (STEAM sequence with parameters: TR
= 3000 ms, 5 spectra during one breath-hold with TE = 12, 24, 36, 48, and 72
ms, voxel size 40x30x25 mm). Automatic and manual shimming were combined to
reach water line width below 50 Hz. Volume of interest position in liver
segments V/VIII was carefully controlled during follow-up examinations.
To calculate hepatic fat volume (HFV),
the hepatic FF
value from the HISTO protocol was first recalculated to the hepatic fat content
(HFC) according to Longo [3] and then HFC was multiplied by total liver
volume (TLV). The TLV value was obtained from the automatic segmentation
routine which processes images from e-Dixon VIBE sequence.
Intra- and
extramyocellular fat in the calf muscle and MRI volumetry fat tissue
Spectra from m. tibialis anterior (STEAM, TE=20, 33, 50, 68, 80, 100, 135,180,
270; 20 acquisitions, VOI=15x15x25
mm, see Figure 1) were processed by LCModel and integral values of water and
extra/intra-myocellular lipids (EMCL/IMCL) were corrected for T2 relaxation
times using custom script in MATLAB.
MRI volumetry of visceral and subcutaneous fat was performed from one
HASTE image (5 mm slice thickness) measured at the level of the 3rd
lumbar vertebra by manual segmentation in ITK-SNAP software.
Statistical
evaluation
Results were statistically evaluated by one-way repeated measures ANOVA and
Sidak’s multiple comparison test. P value <0.05 was considered statistically
significant.
RESULTS
After the KD, the volume of visceral adipose tissue
decreased by 7% (p=0.005), that of subcutaneous adipose tissue by 6%
(p<0.001) and also volume of muscle decreased by 3% (p=0.002). HFC, TLV and
HFV also decreased significantly during KD (ΔHFC = -2.7±0.6%, p<0.001; ΔTLV = -223±27
ml, p<0.0001; and ΔHFV = -69±20 ml, p<0.001, respectively). Both HFC and HFV
values remained reduced after realimentation (see Table 1) but TLV increased by
105±21 ml (p<0.001). In 10 women who had hepatic steatosis (above 5%
HFC), the decrease in liver steatosis was more pronounced (ΔHFC = 4.8±1.1% and
ΔHFV = 132±34 ml) compared to those with normal liver fat (ΔHFC = 0.9±0.3% and
ΔHFV = 16±4 ml).
The total amount of lipids deposited in the muscle
increased only slightly (increase in fat fraction by 0.34±0.15%, p=0.02) after KD.
A more detailed analysis of the MR spectra showed that this increase resulted
mainly due to an intramyocellular component (see Table 1). DISCUSSION
In our group of obese women, the administration of isocaloric KD resulted
in reduction of visceral and subcutaneous adipose tissue and a decrease in hepatic
fat content. The decrease and then subsequent increase in liver volume during
realimentation can be explained by a decrease in lipid volume (significant decrease
in HFV during KD) and, more importantly, by changes in hepatic glycogen, which was
likely to be diminished on KD and resynthesized after realimentation with
carbohydrates. Excessive release of lipids from adipose tissue and liver
probably causes an adverse increase in IMCL during KD.CONCLUSION
In our interventional metabolic study we demonstrated a positive
metabolic effect of ketosis induction on adipose and hepatic tissue in obese
women. Importantly, the results are not biased by a reduction in caloric intake
that is common in other ketogenic diet trials. Acknowledgements
Supported by Ministry of
Health of the Czech Republic, grant numbers: NU20J-01-00005 and DRO („Institute
for Clinical and Experimental Medicine – IKEM, IN 00023001“).References
1. Dyson
PA. J Hum Nutr Diet 2008;21(6):530-538. doi:
10.1111/j.1365-277X.2008.00896.x.
2. Watanabe
M, et al. Obes Rev 2020;21(8):e13024. doi: 10.1111/obr.13024.
3. Longo R, et
al. J Magn Reson
Imaging 1995;5(3):281-285. doi:
10.1002/jmri.1880050311.